Multiple myeloma specialist named inaugural director of blood cancer center
Click Here to Manage Email Alerts
Faith E. Davies, MD, has been appointed the inaugural director of Center for Blood Cancers at NYU Langone Health’s Perlmutter Cancer Center.
Davies currently serves as director of the clinical myeloma program at Perlmutter Cancer Center and professor in the department of medicine at NYU Grossman School of Medicine.
She previously served as medical director of the Myeloma Institute at University of Arkansas for Medical Sciences.
In her new role, she will strive to enhance Center for Blood Cancers’ clinical and translational research programs, recruit new researchers, and oversee the development of a biospecimens resource to facilitate blood cancer research.
“We are delighted that Dr. Davies will be leading the Center for Blood Cancers,” Michael L. Grossbard, MD, professor in the department of medicine at NYU Grossman School of Medicine and section chief of hematology at Perlmutter Cancer Center, said in a press release. “Her work has been fundamental to revealing the importance of achieving complete remission in myeloma therapy, and under her leadership, the center is poised to extend treatment advances for all blood cancers.”
Davies and her colleagues are developing a clinical trial portfolio focused on immunotherapy approaches. Studies are assessing new immunomodulatory drugs, bispecific antibodies and chimeric antigen receptor T-cell therapies.
“I am excited to lead the Center for Blood Cancers,” Davies said. “Perlmutter Cancer Center has an outstanding team of hematologists and medical oncologists, and I am looking forward to building on this strong foundation to provide improved care for our patients.”
Click Here to Manage Email Alerts